Hey there, time traveller!
This article was published 26/11/2009 (3781 days ago), so information in it may no longer be current.
WINNIPEG —The Lung Association of Manitoba and the Canadian Thoracic Society are hosting a two-day conference in Winnipeg to highlight advances in treating lung disorders and lay out a treatment road map for the future.
Held at the University of Manitoba’s downtown campus starting today, the conference will also examine the $12-billion impact lung disease has on the Canadian economy and health-care system.
At least six million Canadians, or one out of every five people, suffer from asthma, chronic obstructive pulmonary disease, lung cancer, sleep apnea or other forms of lung disease.
Despite the prevalence of pulmonary illnesses, the federal government has only committed four per cent of its research dollars to lung disease, according to conference organizers. By comparison, other diseases have received a greater proportion of funding, including diabetes (23 per cent), cancer (15 per cent), cardiovascular disease (14 per cent) and HIV/AIDS (five per cent).